🇺🇸 FDA
Pipeline program

Colla corii asini

TH-3

Approved small_molecule active

Quick answer

Colla corii asini for Thalassemia is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Thalassemia
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials